ZYGOMYCOSIS: Current approaches to management of patients with haematological malignancies
- 2 September 2009
- journal article
- review article
- Published by Wiley in British Journal of Haematology
- Vol. 146 (6) , 597-606
Abstract
Zygomycosis is an invasive infection that can occur particularly in patients with haematological malignancy. The causative fungi are members of the order Mucorales, and individual species within this group require a high level of laboratory skill to be identified. Zygomycosis can present as rhinocerebral, pulmonary, or disseminated disease, with a rapid clinical course. The optimal management of these cases requires early diagnosis, aggressive antifungal therapy and, when possible, surgical debridement. Founded on clinical experience, but without the benefit of comparative studies, liposomal amphotericin B has become the therapeutic agent of choice. Posaconazole is an orally administered triazole with a demonstrated in vitro and in vivo activity against most Zygomycetes that is comparable to that of amphotericin B. Studies on salvage therapy with posaconazole have yielded promising results, and successful case reports are also available. As an adjuvant approach, iron chelation with deferasirox has shown promising results, although clinical experience is still limited.Keywords
This publication has 64 references indexed in Scilit:
- Delaying Amphotericin B–Based Frontline Therapy Significantly Increases Mortality among Patients with Hematologic Malignancy Who Have ZygomycosisClinical Infectious Diseases, 2008
- Zygomycetes Hyphae Trigger an Early, Robust Proinflammatory Response in Human Polymorphonuclear Neutrophils through Toll-Like Receptor 2 Induction but Display Relative Resistance to Oxidative DamageAntimicrobial Agents and Chemotherapy, 2008
- In vitro activities of combinations of amphotericin B, posaconazole and four other agents against RhizopusJournal of Antimicrobial Chemotherapy, 2008
- In Vitro Susceptibilities of 217 Clinical Isolates of Zygomycetes to Conventional and New Antifungal AgentsAntimicrobial Agents and Chemotherapy, 2007
- Posaconazole Is Effective as Salvage Therapy in Zygomycosis: A Retrospective Summary of 91 CasesClinical Infectious Diseases, 2006
- Lovastatin Has Significant Activity against Zygomycetes and Interacts Synergistically with VoriconazoleAntimicrobial Agents and Chemotherapy, 2006
- PCR based identification and discrimination of agents of mucormycosis and aspergillosis in paraffin wax embedded tissueJournal of Clinical Pathology, 2005
- Increasing Volume and Changing Characteristics of Invasive Pulmonary Aspergillosis on Sequential Thoracic Computed Tomography Scans in Patients With NeutropeniaJournal of Clinical Oncology, 2001
- Synergistic action of amphotericin B and rifampin against Rhizopus speciesAntimicrobial Agents and Chemotherapy, 1987
- Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute LeukemiaAnnals of Internal Medicine, 1966